Skip to main content
Top
Published in: BMC Health Services Research 1/2014

Open Access 01-12-2014 | Research article

Transferability of health cost evaluation across locations in oncology: cluster and principal component analysis as an explorative tool

Authors: Lionel Perrier, Alessandra Buja, Giuseppe Mastrangelo, Patrick Sylvestre Baron, Françoise Ducimetière, Petrus J Pauwels, Carlo Riccardo Rossi, François Noël Gilly, Amaury Martin, Bertrand Favier, Fadila Farsi, Mathieu Laramas, Vincenzo Baldo, Olivier Collard, Dominic Cellier, Jean-Yves Blay, Isabelle Ray-Coquard

Published in: BMC Health Services Research | Issue 1/2014

Login to get access

Abstract

Background

The transferability of economic evaluation in health care is of increasing interest in today’s globalized environment. Here, we propose a methodology for assessing the variability of data elements in cost evaluations in oncology. This method was tested in the context of the European Network of Excellence “Connective Tissues Cancers Network”.

Methods

Using a database that was previously aimed at exploring sarcoma management practices in Rhône-Alpes (France) and Veneto (Italy), we developed a model to assess the transferability of health cost evaluation across different locations. A nested data structure with 60 final factors of variability (e.g., unit cost of chest radiograph) within 16 variability areas (e.g., unit cost of imaging) within 12 objects (e.g., diagnoses) was produced in Italy and France, separately. Distances between objects were measured by Euclidean distance, Mahalanobis distance, and city-block metric. A hierarchical structure using cluster analysis (CA) was constructed. The objects were also represented by their projections and area of variability through correlation studies using principal component analysis (PCA). Finally, a hierarchical clustering based on principal components was performed.

Results

CA suggested four clusters of objects: chemotherapy in France; follow-up with relapse in Italy; diagnosis, surgery, radiotherapy, chemotherapy, and follow-up without relapse in Italy; and diagnosis, surgery, and follow-up with or without relapse in France. The variability between clusters was high, suggesting a lower transferability of results. Also, PCA showed a high variability (i.e. lower transferability) for diagnosis between both countries with regard to the quantities and unit costs of biopsies.

Conclusion

CA and PCA were found to be useful for assessing the variability of cost evaluations across countries. In future studies, regression methods could be applied after these methods to elucidate the determinants of the differences found in these analyses.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nixon J, Rice S, Drummond M, Boulenger S, Ulmann P, de Pouvourville G: Guidelines for completing the EURONHEED transferability information checklists. Eur J Health Econ. 2009, 10: 157-165. 10.1007/s10198-008-0115-4.CrossRefPubMed Nixon J, Rice S, Drummond M, Boulenger S, Ulmann P, de Pouvourville G: Guidelines for completing the EURONHEED transferability information checklists. Eur J Health Econ. 2009, 10: 157-165. 10.1007/s10198-008-0115-4.CrossRefPubMed
2.
go back to reference Eldessouki R, Smith MD: Health care system information sharing: a step toward better health globally. Value Health Regional Issues. 2012, 1: 118-129. 10.1016/j.vhri.2012.03.022.CrossRef Eldessouki R, Smith MD: Health care system information sharing: a step toward better health globally. Value Health Regional Issues. 2012, 1: 118-129. 10.1016/j.vhri.2012.03.022.CrossRef
3.
go back to reference Drummond M, Manca A, Sculpher M: Increasing the transferability of economic evaluations: recommendations for the design, analysis, and reporting of studies. Int J Technol Assess Health Care. 2005, 21: 165-171.PubMed Drummond M, Manca A, Sculpher M: Increasing the transferability of economic evaluations: recommendations for the design, analysis, and reporting of studies. Int J Technol Assess Health Care. 2005, 21: 165-171.PubMed
4.
go back to reference Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A: Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess. 2004, 8: 1-192. 10.3310/hta8490.CrossRef Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A: Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess. 2004, 8: 1-192. 10.3310/hta8490.CrossRef
5.
go back to reference Drummond MF, Bloom BS, Carrin G, Hillman AL, Hutchings HC, Knill-Jones RP, de Pouvourville G, Torfs K: Issues in the cross-national assessment of health technology. Int J Technol Assess Health Care. 1992, 8: 671-682.CrossRefPubMed Drummond MF, Bloom BS, Carrin G, Hillman AL, Hutchings HC, Knill-Jones RP, de Pouvourville G, Torfs K: Issues in the cross-national assessment of health technology. Int J Technol Assess Health Care. 1992, 8: 671-682.CrossRefPubMed
6.
go back to reference Goeree R, He J, O’Reilly D, Tarride JE, Xie F, Lim M, Burke N: Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application. Clinicoecon Outcomes Res. 2011, 3: 89-104. 10.2147/CEOR.S14404.CrossRefPubMedPubMedCentral Goeree R, He J, O’Reilly D, Tarride JE, Xie F, Lim M, Burke N: Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application. Clinicoecon Outcomes Res. 2011, 3: 89-104. 10.2147/CEOR.S14404.CrossRefPubMedPubMedCentral
7.
go back to reference Drummond M, Barbieri M, Cook J, Glick HA, Lis J, Malik F, Reed SD, Rutten F, Sculpher M, Severens J: Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report. Value Health. 2009, 12: 409-418. 10.1111/j.1524-4733.2008.00489.x.CrossRefPubMed Drummond M, Barbieri M, Cook J, Glick HA, Lis J, Malik F, Reed SD, Rutten F, Sculpher M, Severens J: Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report. Value Health. 2009, 12: 409-418. 10.1111/j.1524-4733.2008.00489.x.CrossRefPubMed
8.
go back to reference Manca A, Sculpher MJ, Goeree R: The analysis of multinational cost-effectiveness data for reimbursement decisions: a critical appraisal of recent methodological developments. Pharmacoeconomics. 2010, 28: 1079-1096. 10.2165/11537760-000000000-00000.CrossRefPubMed Manca A, Sculpher MJ, Goeree R: The analysis of multinational cost-effectiveness data for reimbursement decisions: a critical appraisal of recent methodological developments. Pharmacoeconomics. 2010, 28: 1079-1096. 10.2165/11537760-000000000-00000.CrossRefPubMed
9.
go back to reference Rice N, Jones A: Multilevel models and health economics. Health Econ. 1997, 6: 561-575. 10.1002/(SICI)1099-1050(199711)6:6<561::AID-HEC288>3.0.CO;2-X.CrossRefPubMed Rice N, Jones A: Multilevel models and health economics. Health Econ. 1997, 6: 561-575. 10.1002/(SICI)1099-1050(199711)6:6<561::AID-HEC288>3.0.CO;2-X.CrossRefPubMed
10.
go back to reference Grieve R, Nixon R, Thompson SG, Normand C: Using multilevel models for assessing the variability of multinational resource use and cost data. Health Econ. 2005, 14: 185-196. 10.1002/hec.916.CrossRefPubMed Grieve R, Nixon R, Thompson SG, Normand C: Using multilevel models for assessing the variability of multinational resource use and cost data. Health Econ. 2005, 14: 185-196. 10.1002/hec.916.CrossRefPubMed
11.
go back to reference Grieve R, Nixon R, Thompson SG, Cairns J: Multilevel models for estimating incremental net benefits in multinational studies. Health Econ. 2007, 16: 815-826. 10.1002/hec.1198.CrossRefPubMed Grieve R, Nixon R, Thompson SG, Cairns J: Multilevel models for estimating incremental net benefits in multinational studies. Health Econ. 2007, 16: 815-826. 10.1002/hec.1198.CrossRefPubMed
12.
go back to reference Pinto EM, Willan AR, O’Brien BJ: Cost-effectiveness analysis for multinational clinical trials. Stat Med. 2005, 24: 1965-1982. 10.1002/sim.2078.CrossRefPubMed Pinto EM, Willan AR, O’Brien BJ: Cost-effectiveness analysis for multinational clinical trials. Stat Med. 2005, 24: 1965-1982. 10.1002/sim.2078.CrossRefPubMed
13.
go back to reference Willan AR, Pinto EM, O’Brien BJ, Kaul P, Goeree R, Lynd L, Armstrong PW: Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis. Health Econ. 2005, 14: 327-338. 10.1002/hec.969.CrossRefPubMed Willan AR, Pinto EM, O’Brien BJ, Kaul P, Goeree R, Lynd L, Armstrong PW: Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis. Health Econ. 2005, 14: 327-338. 10.1002/hec.969.CrossRefPubMed
14.
go back to reference Manca A, Lambert PC, Sculpher M, Rice N: Cost-effectiveness analysis using data from multinational trials: the use of bivariate hierarchical modeling. Med Decis Making. 2007, 27: 471-490. 10.1177/0272989X07302132.CrossRefPubMedPubMedCentral Manca A, Lambert PC, Sculpher M, Rice N: Cost-effectiveness analysis using data from multinational trials: the use of bivariate hierarchical modeling. Med Decis Making. 2007, 27: 471-490. 10.1177/0272989X07302132.CrossRefPubMedPubMedCentral
15.
go back to reference Thompson SG, Nixon RM, Grieve R: Addressing the issues that arise in analysing multicentre cost data, with application to a multinational study. J Health Econ. 2006, 25: 1015-1028. 10.1016/j.jhealeco.2006.02.001.CrossRefPubMed Thompson SG, Nixon RM, Grieve R: Addressing the issues that arise in analysing multicentre cost data, with application to a multinational study. J Health Econ. 2006, 25: 1015-1028. 10.1016/j.jhealeco.2006.02.001.CrossRefPubMed
16.
go back to reference Pang F: The application of multilevel modeling and cluster analysis to multinational economic evaluation data [abstract]. Value Health. 1999, 2: s138-10.1016/S1098-3015(11)70849-X.CrossRef Pang F: The application of multilevel modeling and cluster analysis to multinational economic evaluation data [abstract]. Value Health. 1999, 2: s138-10.1016/S1098-3015(11)70849-X.CrossRef
17.
go back to reference Perrier L, Buja A, Mastrangelo G, Vecchiato A, Sandonà P, Ducimetière F, Blay JY, Gilly FN, Siani C, Biron P, Ranchère-Vince D, Decouvelaere AV, Thiesse P, Bergeron C, Dei Tos AP, Coindre JM, Rossi CR, Ray-Coquard I: Clinicians’ adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions. BMC Health Serv Res. 2012, 28: 82-10.1186/1472-6963-12-82.CrossRef Perrier L, Buja A, Mastrangelo G, Vecchiato A, Sandonà P, Ducimetière F, Blay JY, Gilly FN, Siani C, Biron P, Ranchère-Vince D, Decouvelaere AV, Thiesse P, Bergeron C, Dei Tos AP, Coindre JM, Rossi CR, Ray-Coquard I: Clinicians’ adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions. BMC Health Serv Res. 2012, 28: 82-10.1186/1472-6963-12-82.CrossRef
19.
go back to reference Ray-Coquard I, Montesco MC, Coindre JM, Dei Tos AP, Lurkin A, Ranchère-Vince D, Vecchiato A, Decouvelaere AV, Mathoulin-Pélissier S, Albert S, Cousin P, Cellier D, Toffolatti L, Rossi CR, Blay JY: Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions. Ann Oncol. 2012, 23: 2442-2449. 10.1093/annonc/mdr610.CrossRefPubMedPubMedCentral Ray-Coquard I, Montesco MC, Coindre JM, Dei Tos AP, Lurkin A, Ranchère-Vince D, Vecchiato A, Decouvelaere AV, Mathoulin-Pélissier S, Albert S, Cousin P, Cellier D, Toffolatti L, Rossi CR, Blay JY: Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions. Ann Oncol. 2012, 23: 2442-2449. 10.1093/annonc/mdr610.CrossRefPubMedPubMedCentral
20.
go back to reference Mastrangelo G, Fadda E, Cegolon L, Montesco MC, Ray-Coquard I, Buja A, Fedeli U, Frasson A, Spolaore P, Rossi CR: A European project on incidence, treatment, and outcome of sarcoma. BMC Public Health. 2010, 12; 10: 188-10.1186/1471-2458-10-188.CrossRef Mastrangelo G, Fadda E, Cegolon L, Montesco MC, Ray-Coquard I, Buja A, Fedeli U, Frasson A, Spolaore P, Rossi CR: A European project on incidence, treatment, and outcome of sarcoma. BMC Public Health. 2010, 12; 10: 188-10.1186/1471-2458-10-188.CrossRef
21.
go back to reference Welte R, Feenstra T, Jager H, Leidl R: A decision chart for assessing and improving the transferability of economic evaluation results between countries. Pharmacoeconomics. 2004, 22: 857-876. 10.2165/00019053-200422130-00004.CrossRefPubMed Welte R, Feenstra T, Jager H, Leidl R: A decision chart for assessing and improving the transferability of economic evaluation results between countries. Pharmacoeconomics. 2004, 22: 857-876. 10.2165/00019053-200422130-00004.CrossRefPubMed
22.
go back to reference Manca A, Rice N, Sculpher MJ, Briggs AH: Assessing generasibility by location in trial-based cost-effectiveness analysis: the use of multilevel models. Health Econ. 2005, 14: 471-485. 10.1002/hec.914.CrossRefPubMed Manca A, Rice N, Sculpher MJ, Briggs AH: Assessing generasibility by location in trial-based cost-effectiveness analysis: the use of multilevel models. Health Econ. 2005, 14: 471-485. 10.1002/hec.914.CrossRefPubMed
23.
go back to reference Barbieri M, Drummond M, Willke R, Chancellor J, Jolain B, Towse A: Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring. Value Health. 2005, 8: 10-23. 10.1111/j.1524-4733.2005.03070.x.CrossRefPubMed Barbieri M, Drummond M, Willke R, Chancellor J, Jolain B, Towse A: Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring. Value Health. 2005, 8: 10-23. 10.1111/j.1524-4733.2005.03070.x.CrossRefPubMed
24.
go back to reference Birch S, Gafni A: Economics and the evaluation of health care programmes: generalisability of methods and implications for generalisability of results. Health Policy. 2003, 64: 207-219. 10.1016/S0168-8510(02)00182-3.CrossRefPubMed Birch S, Gafni A: Economics and the evaluation of health care programmes: generalisability of methods and implications for generalisability of results. Health Policy. 2003, 64: 207-219. 10.1016/S0168-8510(02)00182-3.CrossRefPubMed
25.
go back to reference Breiman L, Friedman J, Olshen R, Stone C: Classification and Regression Trees. 1993, Chapman & Hall, Boca Raton Breiman L, Friedman J, Olshen R, Stone C: Classification and Regression Trees. 1993, Chapman & Hall, Boca Raton
26.
go back to reference Cox TF, Cox MA: Multidimensional Scaling. 2001, Chapman & Hall, Boca Raton Cox TF, Cox MA: Multidimensional Scaling. 2001, Chapman & Hall, Boca Raton
27.
go back to reference Statistics toolbox. The Math Works, Inc. User’s Guide (Version 3); 2000. Statistics toolbox. The Math Works, Inc. User’s Guide (Version 3); 2000.
28.
go back to reference Halkidi M, Batistakis Y, Vazirgiannis M: On clustering validation techniques. J Intell Inform Syst. 2001, 17: 107-145. 10.1023/A:1012801612483.CrossRef Halkidi M, Batistakis Y, Vazirgiannis M: On clustering validation techniques. J Intell Inform Syst. 2001, 17: 107-145. 10.1023/A:1012801612483.CrossRef
29.
go back to reference Subhash S, Kumar A: Cluster Analysis and Factor Analysis. The Handbook of Marketing Research, Chapter 18. 2006 Subhash S, Kumar A: Cluster Analysis and Factor Analysis. The Handbook of Marketing Research, Chapter 18. 2006
30.
go back to reference Jolliffe I: Principal Component Analysis. 2010, Springer Verlag, Series in statistics, New York Jolliffe I: Principal Component Analysis. 2010, Springer Verlag, Series in statistics, New York
31.
go back to reference Jackson JE: A User’s Guide to Principal Components. 2003, Wiley & Son, Series in Probability and Statistics, New York Jackson JE: A User’s Guide to Principal Components. 2003, Wiley & Son, Series in Probability and Statistics, New York
33.
go back to reference Glickman SW, Boulding W, Roos JM, Staelin R, Peterson ED, Schulman KA: Alternative pay-for-performance scoring methods: implications for quality improvement and patient outcomes. Med Care. 2009, 47: 1062-1068. 10.1097/MLR.0b013e3181a7e54c.CrossRefPubMed Glickman SW, Boulding W, Roos JM, Staelin R, Peterson ED, Schulman KA: Alternative pay-for-performance scoring methods: implications for quality improvement and patient outcomes. Med Care. 2009, 47: 1062-1068. 10.1097/MLR.0b013e3181a7e54c.CrossRefPubMed
34.
go back to reference Latry P, Martin-Latry K, Labat A e, Molimard M, Peter C: Use of principal component analysis in the evaluation of adherence to statin treatment: a method to determine a potential target population for public health intervention. Fundam Clin Pharmacol. 2011, 25: 528-533. 10.1111/j.1472-8206.2010.00870.x.CrossRefPubMed Latry P, Martin-Latry K, Labat A e, Molimard M, Peter C: Use of principal component analysis in the evaluation of adherence to statin treatment: a method to determine a potential target population for public health intervention. Fundam Clin Pharmacol. 2011, 25: 528-533. 10.1111/j.1472-8206.2010.00870.x.CrossRefPubMed
35.
go back to reference Berdeaux G, Viala M, Roborel De Climens A, Arnould B: Patient-reported benefit of ReSTOR® multi-focal intraocular lenses after cataract surgery: results of principal component analysis on clinical trial data. Health Qual Life Outcomes. 2008, 6: 1-9. 10.1186/1477-7525-6-10.CrossRef Berdeaux G, Viala M, Roborel De Climens A, Arnould B: Patient-reported benefit of ReSTOR® multi-focal intraocular lenses after cataract surgery: results of principal component analysis on clinical trial data. Health Qual Life Outcomes. 2008, 6: 1-9. 10.1186/1477-7525-6-10.CrossRef
36.
go back to reference Barbieri M, Drummond M, Rutten F, Cook J, Glick HA, Lis J, Reed SD, Sculpher M, Severens JL: What do international pharmacoeconomics guidelines say about economic data transferability?. Value Health. 2010, 13: 1028-1037. 10.1111/j.1524-4733.2010.00771.x.CrossRefPubMed Barbieri M, Drummond M, Rutten F, Cook J, Glick HA, Lis J, Reed SD, Sculpher M, Severens JL: What do international pharmacoeconomics guidelines say about economic data transferability?. Value Health. 2010, 13: 1028-1037. 10.1111/j.1524-4733.2010.00771.x.CrossRefPubMed
37.
go back to reference Burn: 37 del 17/04/2007,(Codice interno: 196263) Deliberazione della giunta regionale n°734 del 20 marzo. Prestazioni di chemioterapia e radioterapia; 2007. Burn: 37 del 17/04/2007,(Codice interno: 196263) Deliberazione della giunta regionale n°734 del 20 marzo. Prestazioni di chemioterapia e radioterapia; 2007.
39.
go back to reference Stiller CA, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque MD, Casali PG: Descriptive epidemiology of sarcomas in Europe: report from the rarecare project. Eur J Cancer. 2013, 49: 684-695. 10.1016/j.ejca.2012.09.011.CrossRefPubMed Stiller CA, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque MD, Casali PG: Descriptive epidemiology of sarcomas in Europe: report from the rarecare project. Eur J Cancer. 2013, 49: 684-695. 10.1016/j.ejca.2012.09.011.CrossRefPubMed
40.
go back to reference Standards, Options et Recommandations pour la prise en charge des patients adultes atteints de sarcome des tissus mous, de sarcome utérin ou de tumeur stromale gastro-intestinale. 1995 Standards, Options et Recommandations pour la prise en charge des patients adultes atteints de sarcome des tissus mous, de sarcome utérin ou de tumeur stromale gastro-intestinale. 1995
42.
go back to reference Guo JJ, Jing Y, Nguyen K, Fan H e, Kelton CM: Principal components analysis of drug expenditure and utilisation trends for major therapeutic classes in US Medicaid programmes. J Med Econ. 2008, 11: 671-694. 10.3111/13696990802579966.CrossRefPubMed Guo JJ, Jing Y, Nguyen K, Fan H e, Kelton CM: Principal components analysis of drug expenditure and utilisation trends for major therapeutic classes in US Medicaid programmes. J Med Econ. 2008, 11: 671-694. 10.3111/13696990802579966.CrossRefPubMed
43.
go back to reference Holmes GM, Pink GH: Adoption and perceived effectiveness of financial improvement strategies in critical access hospitals. J Rural Health. 2012, 28: 92-100. 10.1111/j.1748-0361.2011.00368.x.CrossRefPubMed Holmes GM, Pink GH: Adoption and perceived effectiveness of financial improvement strategies in critical access hospitals. J Rural Health. 2012, 28: 92-100. 10.1111/j.1748-0361.2011.00368.x.CrossRefPubMed
44.
go back to reference Ding C, He X: K-Means Clustering Via Principal Component Analysis. Proceeding ICML’04: Proceedings of the 21th International Conference on Machine Learning. 2004, ACM, New York Ding C, He X: K-Means Clustering Via Principal Component Analysis. Proceeding ICML’04: Proceedings of the 21th International Conference on Machine Learning. 2004, ACM, New York
Metadata
Title
Transferability of health cost evaluation across locations in oncology: cluster and principal component analysis as an explorative tool
Authors
Lionel Perrier
Alessandra Buja
Giuseppe Mastrangelo
Patrick Sylvestre Baron
Françoise Ducimetière
Petrus J Pauwels
Carlo Riccardo Rossi
François Noël Gilly
Amaury Martin
Bertrand Favier
Fadila Farsi
Mathieu Laramas
Vincenzo Baldo
Olivier Collard
Dominic Cellier
Jean-Yves Blay
Isabelle Ray-Coquard
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2014
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-014-0537-x

Other articles of this Issue 1/2014

BMC Health Services Research 1/2014 Go to the issue